BITGF:OTC-Biotage AB (publ) (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 16.50

Change

0.00 (0.00)%

Market Cap

USD 0.77B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Biotage AB (publ) (BITGF) Stock Analysis:
Based on the Biotage AB (publ) stock forecasts from 0 analysts, the average analyst target price for Biotage AB (publ) is not available over the next 12 months. Biotage AB (publ)’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biotage AB (publ) is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, Biotage AB (publ)’s stock price was USD 16.50. Biotage AB (publ)’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -25.00% over the last year.

No recent analyst target price found for Biotage AB (publ)
No recent average analyst rating found for Biotage AB (publ)

About

Biotage AB (publ), a life science company, provides solutions, knowledge, and experience in the areas of organic and analytical chemistry, as well as for industrial applications in the United States, Europe, Japan, China, and internationally. It offers sample preparation solution ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-05-21 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BTHI Big Time Holdings, Inc

N/A

USD151.65B N/A N/A
ERGN Ergo Science Corporation

N/A

USD55.23B N/A N/A
ANCUF Alimentation Couche-Tard Inc

N/A

USD42.00B 16.57 9.43
FYRTF FamilyMart Co., Ltd

N/A

USD24.28B 60.20 N/A
EPOKF Epiroc AB (publ)

N/A

USD23.71B 19.70 N/A
EPKAF Epiroc AB (publ)

N/A

USD20.70B 18.20 N/A
ARGNF argenx SE

N/A

USD20.45B N/A N/A
AMCRY Amcor plc

N/A

USD17.90B 19.64 N/A
STMZF Scottish Mortgage Investment T..

N/A

USD14.72B 2.00 N/A
NDVLF New World Development Company ..

N/A

USD13.20B 5.40 N/A

ETFs Containing BITGF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification ()
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.94% N/A N/A 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -43.94% N/A N/A 17% F
Trailing 12 Months  
Capital Gain -25.00% N/A N/A 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.00% N/A N/A 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 26.43% N/A N/A 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.43% N/A N/A 62% D-
Risk Return Profile  
Volatility (Standard Deviation) 29.20% N/A N/A 69% D+
Risk Adjusted Return 90.52% N/A N/A 97% A+
Market Capitalization 0.77B N/A N/A 64% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 40.60 N/A N/A 14% F
Price/Book Ratio 12.69 N/A N/A 10% F
Price / Cash Flow Ratio 5.00 N/A N/A 26% F
EV/EBITDA 280.89 N/A N/A 2% F
Management Effectiveness  
Return on Equity 24.47% N/A N/A 89% B+
Return on Invested Capital 21.45% N/A N/A 83% B
Return on Assets 10.60% N/A N/A 93% A
Debt to Equity Ratio 15.58% N/A N/A 60% D-
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.85 N/A N/A 50% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.